What is the role of HLA-B27 in spondyloarthropathies?
Authors:
- Paraskevi V. VoulgariPVParaskevi V. Voulgari
- Alexandros A. DrososADAlexandros A. Drosos
- 1 June 2011
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 10 (8) , 464-468
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Molecular mechanisms of HLA association with autoimmune diseasesTissue Antigens, 2008
- Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part IArthritis & Rheumatism, 2007
- The mystery of HLA–B27: If it isn't one thing, it's anotherArthritis & Rheumatism, 2007
- HLA‐B27 lacking associated β2‐microglobulin rearranges to auto‐display or cross‐display residues 169–181: a novel molecular mechanism for spondyloarthropathiesFEBS Letters, 2004
- Epidemiology of ankylosing spondylitis in Northwest Greece, 1983-2002Rheumatology, 2004
- Ankylosing spondylitis: a β2m–deposition disease?Trends in Immunology, 2003
- Genetic aspects of ankylosing spondylitisBest Practice & Research Clinical Rheumatology, 2002
- The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHCCell, 1992
- Identification of self peptides bound to purified HLA-B27Nature, 1991
- The HLA-A,B gene frequencies in the world: Migration or selection?Human Immunology, 1980